“Peg-Interferon Plus Ribavirin in Chronic Hepatitis C: Cost-Efficacy and Pharmacoutilization in Clinical Practice”. Farmeconomia. Health economics and therapeutic pathways 9, no. 4 (January 15, 2008): 173–181. Accessed October 29, 2025. https://journals.seedstm.com/index.php/FE/article/view/235.